[Pharmacodynamic properties of prenylamine].
D000818:Animals; D001011:Aorta / Q000187:drug effects; D002395:Catecholamines / Q000494:pharmacology; D004347:Drug Interactions; D006168:Guinea Pigs; D006325:Heart Atria; D007422:Intestines / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D009200:Myocardial Contraction / Q000187:drug effects; D010276:Parasympatholytics; D011299:Prenylamine / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D012110:Reserpine / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects
D002395:Catecholamines; D010276:Parasympatholytics; D011941:Receptors, Adrenergic; D012110:Reserpine; D011299:Prenylamine
Proprietà farmacodinamiche della prenilamina.